Our goal was to examine the presence of PhosphatidylSerine bearing microparticles (PS + MPs) and Annexin A5 in plasma of HCV cirrhotics with and without HCC and to explore if the lower plasma Annexin A5/PS + MP ratio in these patients could predict the development of PVT. Here, ANXA5 is linked to hepatocellular carcinoma.